Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”
Circulation · 2023
DOI: 10.1161/circulationaha.122.062745 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2023. Verfasst von Maria Inês Schmidt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetes Mellitus, Type 2. Die Arbeit nennt 3 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
ORCID-Profile: Maria Inês Schmidt, Bruce B Duncan
Zitieren
APA
Schmidt, M. I., Bracco, P. A., & Duncan, B. B. (2023). Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”. Circulation. https://doi.org/10.1161/circulationaha.122.062745
Vancouver
Schmidt MI, Bracco PA, Duncan BB. Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”. Circulation. 2023. doi:10.1161/circulationaha.122.062745
BibTeX
@article{Schmidt2023,
author = {Schmidt, Maria Inês and Bracco, Paula A and Duncan, Bruce B},
title = {Letter by Schmidt et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”},
journal = {Circulation},
year = {2023},
doi = {10.1161/circulationaha.122.062745}
}
EUVIMED